Case report of a fatal rectal haemorrhage in a person with severe haemophilia A receiving emicizumab and high-dose bypassing agents in the HAVEN 1 study

被引：6

作者：

Khoo, Liane ^{[1
]}

Matthews, Stephen ^{[1
]}

Kershaw, Geoffrey ^{[1
]}

Pidcock, Michael ^{[2
]}

Phipps, Alex ^{[3
]}

Kiialainen, Anna ^{[4
]}

Chang, Tiffany ^{[5
]}

机构：

[1] Royal Prince Alfred Hosp, Inst Haematol, Sydney, NSW 2050, Australia

[2] Canberra Hosp, ACT Pathol, Canberra, ACT, Australia

[3] F Hoffmann La Roche Ltd, Welwyn Garden City, Herts, England

[4] F Hoffmann La Roche Ltd, Basel, Switzerland

[5] Genentech Inc, San Francisco, CA 94080 USA

来源：

HAEMOPHILIA | 2020年 / 26卷 / 06期

关键词：

PROPHYLAXIS; INHIBITORS;

D O I：

10.1111/hae.14110

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E340 / E343

页数：4

共 10 条

[1] Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors [J].

Berntorp, E. .

HAEMOPHILIA, 2009, 15 (01) :3-10

[2] Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series [J].

Ettingshausen, C. Escuriola ;

Kreuz, W. .

HAEMOPHILIA, 2010, 16 (01) :90-100

[3]

Genentech, 2018, HEMLIBRA EM KXWH INJ

[4] A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model [J].

Kitazawa, Takehisa ;

Igawa, Tomoyuki ;

Sampei, Zenjiro ;

Muto, Atsushi ;

Kojima, Tetsuo ;

Soeda, Tetsuhiro ;

Yoshihashi, Kazutaka ;

Okuyama-Nishida, Yukiko ;

Saito, Hiroyuki ;

Tsunoda, Hiroyuki ;

Suzuki, Tsukasa ;

Adachi, Hideki ;

Miyazaki, Taro ;

Ishii, Shinya ;

Kamata-Sakurai, Mika ;

Iida, Takeo ;

Harada, Aya ;

Esaki, Keiko ;

Funaki, Miho ;

Moriyama, Chifumi ;

Tanaka, Eriko ;

Kikuchi, Yasufumi ;

Wakabayashi, Tetsuya ;

Wada, Manabu ;

Goto, Masaaki ;

Toyoda, Takeshi ;

Ueyama, Atsunori ;

Suzuki, Sachiyo ;

Haraya, Kenta ;

Tachibana, Tatsuhiko ;

Kawabe, Yoshiki ;

Shima, Midori ;

Yoshioka, Akira ;

Hattori, Kunihiro .

NATURE MEDICINE, 2012, 18 (10) :1570-U177

[5] Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors [J].

Konkle, B. A. ;

Ebbesen, L. S. ;

Erhardtsen, E. ;

Bianco, R. P. ;

Lissitchkov, T. ;

Rusen, L. ;

Serban, M. A. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (09) :1904-1913

[6] Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors [J].

Leissinger, Cindy ;

Gringeri, Alessandro ;

Antmen, Bulent ;

Berntorp, Erik ;

Biasoli, Chiara ;

Carpenter, Shannon ;

Cortesi, Paolo ;

Jo, Hyejin ;

Kavakli, Kaan ;

Lassila, Riitta ;

Morfini, Massimo ;

Negrier, Claude ;

Rocino, Angiola ;

Schramm, Wolfgang ;

Serban, Margit ;

Uscatescu, Marusia Valentina ;

Windyga, Jerzy ;

Zulfikar, Bulent ;

Mantovani, Lorenzo .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) :1684-1692

[7] European Study on Orthopaedic Status of haemophilia patients with inhibitors [J].

Morfini, M. ;

Haya, S. ;

Tagariello, G. ;

Pollmann, H. ;

Quintana, M. ;

Siegmund, B. ;

Stieltjes, N. ;

Dolan, G. ;

Tusell, J. .

HAEMOPHILIA, 2007, 13 (05) :606-612

[8] Emicizumab Prophylaxis in Hemophilia A with Inhibitors [J].

Oldenburg, Johannes ;

Mahlangu, Johnny N. ;

Kim, Benjamin ;

Schmitt, Christophe ;

Callaghan, Michael U. ;

Young, Guy ;

Santagostino, Elena ;

Kruse-Jarres, Rebecca ;

Negrier, Claude ;

Kessler, Craig ;

Valente, Nancy ;

Asikanius, Elina ;

Levy, Gallia G. ;

Windyga, Jerzy ;

Shima, Midori .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :809-818

[9] Impact of inhibitors on hemophilia A mortality in the United States [J].

Walsh, Christopher E. ;

Soucie, J. Michael ;

Miller, Connie H. .

AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (05) :400-405

[10] Factor VIII inhibitors in hemophilia A: rationale and latest evidence [J].

Witmer, Char ;

Young, Guy .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (01) :59-72

← 1 →